跳至主要内容
临床试验/NCT06337227
NCT06337227招募中不适用

Potential Role of Sirtuins As Epigenetic Biomarkers for the Clinical Management of the Patient with Atherosclerosis or Calcific Aortic Stenosis

IRCCS SYNLAB SDN1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2023年10月19日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3
试验地点
1
主要终点
To evaluate by analysis of data obtained from NGS techniques whether and which proteins belonging to the Sirtuin family may be deregulated in patients with atherosclerosis or calcific aortic stenosis

研究概览

简要总结

The project aims to shed light on the role of Sirtuins, enzymes belonging to the third class of histone deacetylases (class III) involved in epigenetic modifications (deacetylation), focusing mainly on Sirtuin 6 (SIRT6), as a regulator of atherosclerosis and severe aortic valve stenosis through molecular-based and epigenetic studies in human VSMC cells.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with atherosclerosis or calcific aortic stenosis with and without diabetes older than 18 years of either sex;
  • Patients without atherosclerosis undergoing surgical procedure for endocarditis;
  • Patients who will have signed informed consent

排除标准

  • Patients for whom biological material cannot be recovered for study purposes;
  • Patients who refuse to participate in the study

结局指标

主要结局

To evaluate by analysis of data obtained from NGS techniques whether and which proteins belonging to the Sirtuin family may be deregulated in patients with atherosclerosis or calcific aortic stenosis

时间窗: 36 months

次要结局

  • To evaluate the experimental results achieved in the clinical-diagnostic context(36 months)

研究者

发起方
IRCCS SYNLAB SDN
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验